Sana Biotechnology, Inc. (SANA)
3.93
-0.16
(-3.91%)
USD |
NASDAQ |
Aug 28, 16:00
3.925
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Cash from Operations (Quarterly) : -32.79M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -32.79M |
| March 31, 2026 | -37.38M |
| December 31, 2025 | -32.64M |
| September 30, 2025 | -29.43M |
| June 30, 2025 | -33.10M |
| March 31, 2025 | -48.66M |
| December 31, 2024 | -47.16M |
| September 30, 2024 | -51.82M |
| June 30, 2024 | -58.54M |
| March 31, 2024 | -65.63M |
| December 31, 2023 | -51.96M |
| September 30, 2023 | -63.55M |
| June 30, 2023 | -58.80M |
| Date | Value |
|---|---|
| March 31, 2023 | -79.27M |
| December 31, 2022 | -76.07M |
| September 30, 2022 | -64.80M |
| June 30, 2022 | -71.48M |
| March 31, 2022 | -77.71M |
| December 31, 2021 | -110.10M |
| September 30, 2021 | -50.49M |
| June 30, 2021 | -40.56M |
| March 31, 2021 | -49.91M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -29.55M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Twist Bioscience Corp. | 1.115M |
| Beam Therapeutics, Inc. | -66.10M |
| Prime Medicine, Inc. | -41.05M |
| Intellia Therapeutics, Inc. | -83.11M |
| Moderna, Inc. | -526.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -87.52M |
| Cash from Financing (Quarterly) | 93.58M |
| Free Cash Flow | -135.06M |
| Free Cash Flow Per Share (Quarterly) | -0.1164 |
| Free Cash Flow to Equity (Quarterly) | -32.82M |
| Free Cash Flow to Firm (Quarterly) | -34.41M |
| Free Cash Flow Yield | -12.40% |